APO Research
Talk to an analyst

APO RESEARCH · REPORT

Over-The-Counter (OTC) Pet Medication

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Over-The-Counter (OTC) Pet Medication Market Outlook and Growth Opportunities 2026

26 December 2025191 pages

Choose your research edition.

Industry ResearchOver-The-Counter (OTC) Pet Medication Industry Research Report 2026133 pages · $2,950 USDIndustry Growth & TrendsGlobal Over-The-Counter (OTC) Pet Medication Industry Growth and Trends Forecast to 2032110 pages · $3,450 USDMarket StructureGlobal Over-The-Counter (OTC) Pet Medication Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Over-The-Counter (OTC) Pet Medication Market Outlook and Growth Opportunities 2026191 pages · $4,250 USDMarket Analysis & ForecastGlobal Over-The-Counter (OTC) Pet Medication Market Analysis and Forecast 2026-2032197 pages · $4,950 USD

Market perspective

The global Over-The-Counter (OTC) Pet Medication market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Over-The-Counter (OTC) Pet Medication is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Over-The-Counter (OTC) Pet Medication is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Over-The-Counter (OTC) Pet Medication is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Over-The-Counter (OTC) Pet Medication market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Over-The-Counter (OTC) Pet Medication market include Merck Animal Health, Elanco, Zoetis, Virbac, Vet's Best, Vetoquinol, Sentry, Purdue Pharma L.P. and PetIQ, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Over-The-Counter (OTC) Pet Medication market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Over-The-Counter (OTC) Pet Medication and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Over-The-Counter (OTC) Pet Medication sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Over-The-Counter (OTC) Pet Medication market size, projected growth trends, production technologies, key applications, and end-use industries.

Over-The-Counter (OTC) Pet Medication Segment by Company

Merck Animal Health

Elanco

Zoetis

Virbac

Vet's Best

Vetoquinol

Sentry

Purdue Pharma L.P.

PetIQ

Perrigo

Nutramax Laboratories

Mobedco-Vet

Ceva Santé Animale

Boehringer Ingelheim

Antelope Pets

Over-The-Counter (OTC) Pet Medication Segment by Type

Dogs

Cats

Others

Over-The-Counter (OTC) Pet Medication Segment by Application

Online Sales

Offline Sales

Over-The-Counter (OTC) Pet Medication Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Over-The-Counter (OTC) Pet Medication status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Over-The-Counter (OTC) Pet Medication market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Over-The-Counter (OTC) Pet Medication significant trends, drivers, influence factors in global and regions.

6. To analyze Over-The-Counter (OTC) Pet Medication competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Over-The-Counter (OTC) Pet Medication market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Over-The-Counter (OTC) Pet Medication and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Over-The-Counter (OTC) Pet Medication.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Over-The-Counter (OTC) Pet Medication market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Over-The-Counter (OTC) Pet Medication industry.

Chapter 3: Detailed analysis of Over-The-Counter (OTC) Pet Medication manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Over-The-Counter (OTC) Pet Medication in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Over-The-Counter (OTC) Pet Medication in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Over-The-Counter (OTC) Pet Medication Industry Trends Table 2. Over-The-Counter (OTC) Pet Medication Industry Drivers Table 3. Over-The-Counter (OTC) Pet Medication Industry Opportunities and Challenges Table 4. Over-The-Counter (OTC) Pet Medication Industry Restraints Table 5. Global Over-The-Counter (OTC) Pet Medication Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Over-The-Counter (OTC) Pet Medication Revenue Share by Company (2021-2026) Table 7. Global Over-The-Counter (OTC) Pet Medication Sales Volume by Company (Kg) & (2021-2026) Table 8. Global Over-The-Counter (OTC) Pet Medication Sales Volume Share by Company (2021-2026) Table 9. Global Over-The-Counter (OTC) Pet Medication Average Price (US$/g) of Company (2021-2026) Table 10. Global Over-The-Counter (OTC) Pet Medication Company Ranking, (2024-2026) & (USD Million) Table 11. Global Over-The-Counter (OTC) Pet Medication Key Company Manufacturing Base & Headquarters Table 12. Global Over-The-Counter (OTC) Pet Medication Company, Product Type & Application Table 13. Global Over-The-Counter (OTC) Pet Medication Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Over-The-Counter (OTC) Pet Medication by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Dogs Table 18. Significant Companies of Cats Table 19. Significant Companies of Others Table 20. Global Over-The-Counter (OTC) Pet Medication Sales Volume by Type 2021 VS 2025 VS 2032 (Kg) Table 21. Global Over-The-Counter (OTC) Pet Medication Sales Volume by Type (2021-2026) & (Kg) Table 22. Global Over-The-Counter (OTC) Pet Medication Sales Volume by Type (2027-2032) & (Kg) Table 23. Global Over-The-Counter (OTC) Pet Medication Sales Volume Share by Type (2021-2026) Table 24. Global Over-The-Counter (OTC) Pet Medication Sales Volume Share by Type (2027-2032) Table 25. Global Over-The-Counter (OTC) Pet Medication Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Over-The-Counter (OTC) Pet Medication Sales Value by Type (2021-2026) & (US$ Million) Table 27. Global Over-The-Counter (OTC) Pet Medication Sales Value by Type (2027-2032) & (US$ Million) Table 28. Global Over-The-Counter (OTC) Pet Medication Sales Value Share by Type (2021-2026) Table 29. Global Over-The-Counter (OTC) Pet Medication Sales Value Share by Type (2027-2032) Table 30. Significant Companies of Online Sales Table 31. Significant Companies of Offline Sales Table 32. Global Over-The-Counter (OTC) Pet Medication Sales Volume by Application 2021 VS 2025 VS 2032 (Kg) Table 33. Global Over-The-Counter (OTC) Pet Medication Sales Volume by Application (2021-2026) & (Kg) Table 34. Global Over-The-Counter (OTC) Pet Medication Sales Volume by Application (2027-2032) & (Kg) Table 35. Global Over-The-Counter (OTC) Pet Medication Sales Volume Share by Application (2021-2026) Table 36. Global Over-The-Counter (OTC) Pet Medication Sales Volume Share by Application (2027-2032) Table 37. Global Over-The-Counter (OTC) Pet Medication Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 38. Global Over-The-Counter (OTC) Pet Medication Sales Value by Application (2021-2026) & (US$ Million) Table 39. Global Over-The-Counter (OTC) Pet Medication Sales Value by Application (2027-2032) & (US$ Million) Table 40. Global Over-The-Counter (OTC) Pet Medication Sales Value Share by Application (2021-2026) Table 41. Global Over-The-Counter (OTC) Pet Medication Sales Value Share by Application (2027-2032) Table 42. Global Over-The-Counter (OTC) Pet Medication Sales by Region: 2021 VS 2025 VS 2032 (Kg) Table 43. Global Over-The-Counter (OTC) Pet Medication Sales by Region (2021-2026) & (Kg) Table 44. Global Over-The-Counter (OTC) Pet Medication Sales Market Share by Region (2021-2026) Table 45. Global Over-The-Counter (OTC) Pet Medication Sales by Region (2027-2032) & (Kg) Table 46. Global Over-The-Counter (OTC) Pet Medication Sales Market Share by Region (2027-2032) Table 47. Global Over-The-Counter (OTC) Pet Medication Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 48. Global Over-The-Counter (OTC) Pet Medication Sales Value by Region (2021-2026) & (US$ Million) Table 49. Global Over-The-Counter (OTC) Pet Medication Sales Value Share by Region (2021-2026) Table 50. Global Over-The-Counter (OTC) Pet Medication Sales Value by Region (2027-2032) & (US$ Million) Table 51. Global Over-The-Counter (OTC) Pet Medication Sales Value Share by Region (2027-2032) Table 52. Global Over-The-Counter (OTC) Pet Medication Market Average Price (US$/g) by Region (2021-2026) Table 53. Global Over-The-Counter (OTC) Pet Medication Market Average Price (US$/g) by Region (2027-2032) Table 54. Global Over-The-Counter (OTC) Pet Medication Sales by Country: 2021 VS 2025 VS 2032 (Kg) Table 55. Global Over-The-Counter (OTC) Pet Medication Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 56. Global Over-The-Counter (OTC) Pet Medication Sales by Country (2021-2026) & (Kg) Table 57. Global Over-The-Counter (OTC) Pet Medication Sales Market Share by Country (2021-2026) Table 58. Global Over-The-Counter (OTC) Pet Medication Sales by Country (2027-2032) & (Kg) Table 59. Global Over-The-Counter (OTC) Pet Medication Sales Market Share by Country (2027-2032) Table 60. Global Over-The-Counter (OTC) Pet Medication Sales Value by Country (2021-2026) & (US$ Million) Table 61. Global Over-The-Counter (OTC) Pet Medication Sales Value Market Share by Country (2021-2026) Table 62. Global Over-The-Counter (OTC) Pet Medication Sales Value by Country (2027-2032) & (US$ Million) Table 63. Global Over-The-Counter (OTC) Pet Medication Sales Value Market Share by Country (2027-2032) Table 64. Merck Animal Health Company Information Table 65. Merck Animal Health Business Overview Table 66. Merck Animal Health Over-The-Counter (OTC) Pet Medication Sales (Kg), Value (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 67. Merck Animal Health Over-The-Counter (OTC) Pet Medication Product Portfolio Table 68. Merck Animal Health Recent Development Table 69. Elanco Company Information Table 70. Elanco Business Overview Table 71. Elanco Over-The-Counter (OTC) Pet Medication Sales (Kg), Value (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 72. Elanco Over-The-Counter (OTC) Pet Medication Product Portfolio Table 73. Elanco Recent Development Table 74. Zoetis Company Information Table 75. Zoetis Business Overview Table 76. Zoetis Over-The-Counter (OTC) Pet Medication Sales (Kg), Value (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 77. Zoetis Over-The-Counter (OTC) Pet Medication Product Portfolio Table 78. Zoetis Recent Development Table 79. Virbac Company Information Table 80. Virbac Business Overview Table 81. Virbac Over-The-Counter (OTC) Pet Medication Sales (Kg), Value (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 82. Virbac Over-The-Counter (OTC) Pet Medication Product Portfolio Table 83. Virbac Recent Development Table 84. Vet's Best Company Information Table 85. Vet's Best Business Overview Table 86. Vet's Best Over-The-Counter (OTC) Pet Medication Sales (Kg), Value (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 87. Vet's Best Over-The-Counter (OTC) Pet Medication Product Portfolio Table 88. Vet's Best Recent Development Table 89. Vetoquinol Company Information Table 90. Vetoquinol Business Overview Table 91. Vetoquinol Over-The-Counter (OTC) Pet Medication Sales (Kg), Value (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 92. Vetoquinol Over-The-Counter (OTC) Pet Medication Product Portfolio Table 93. Vetoquinol Recent Development Table 94. Sentry Company Information Table 95. Sentry Business Overview Table 96. Sentry Over-The-Counter (OTC) Pet Medication Sales (Kg), Value (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 97. Sentry Over-The-Counter (OTC) Pet Medication Product Portfolio Table 98. Sentry Recent Development Table 99. Purdue Pharma L.P. Company Information Table 100. Purdue Pharma L.P. Business Overview Table 101. Purdue Pharma L.P. Over-The-Counter (OTC) Pet Medication Sales (Kg), Value (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 102. Purdue Pharma L.P. Over-The-Counter (OTC) Pet Medication Product Portfolio Table 103. Purdue Pharma L.P. Recent Development Table 104. PetIQ Company Information Table 105. PetIQ Business Overview Table 106. PetIQ Over-The-Counter (OTC) Pet Medication Sales (Kg), Value (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 107. PetIQ Over-The-Counter (OTC) Pet Medication Product Portfolio Table 108. PetIQ Recent Development Table 109. Perrigo Company Information Table 110. Perrigo Business Overview Table 111. Perrigo Over-The-Counter (OTC) Pet Medication Sales (Kg), Value (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 112. Perrigo Over-The-Counter (OTC) Pet Medication Product Portfolio Table 113. Perrigo Recent Development Table 114. Nutramax Laboratories Company Information Table 115. Nutramax Laboratories Business Overview Table 116. Nutramax Laboratories Over-The-Counter (OTC) Pet Medication Sales (Kg), Value (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 117. Nutramax Laboratories Over-The-Counter (OTC) Pet Medication Product Portfolio Table 118. Nutramax Laboratories Recent Development Table 119. Mobedco-Vet Company Information Table 120. Mobedco-Vet Business Overview Table 121. Mobedco-Vet Over-The-Counter (OTC) Pet Medication Sales (Kg), Value (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 122. Mobedco-Vet Over-The-Counter (OTC) Pet Medication Product Portfolio Table 123. Mobedco-Vet Recent Development Table 124. Ceva Santé Animale Company Information Table 125. Ceva Santé Animale Business Overview Table 126. Ceva Santé Animale Over-The-Counter (OTC) Pet Medication Sales (Kg), Value (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 127. Ceva Santé Animale Over-The-Counter (OTC) Pet Medication Product Portfolio Table 128. Ceva Santé Animale Recent Development Table 129. Boehringer Ingelheim Company Information Table 130. Boehringer Ingelheim Business Overview Table 131. Boehringer Ingelheim Over-The-Counter (OTC) Pet Medication Sales (Kg), Value (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 132. Boehringer Ingelheim Over-The-Counter (OTC) Pet Medication Product Portfolio Table 133. Boehringer Ingelheim Recent Development Table 134. Antelope Pets Company Information Table 135. Antelope Pets Business Overview Table 136. Antelope Pets Over-The-Counter (OTC) Pet Medication Sales (Kg), Value (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 137. Antelope Pets Over-The-Counter (OTC) Pet Medication Product Portfolio Table 138. Antelope Pets Recent Development Table 139. Key Raw Materials Table 140. Raw Materials Key Suppliers Table 141. Over-The-Counter (OTC) Pet Medication Distributors List Table 142. Over-The-Counter (OTC) Pet Medication Customers List Table 143. Research Programs/Design for This Report Table 144. Authors List of This Report Table 145. Secondary Sources Table 146. Primary Sources List of Figures Figure 1. Over-The-Counter (OTC) Pet Medication Product Image Figure 2. Global Over-The-Counter (OTC) Pet Medication Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Over-The-Counter (OTC) Pet Medication Sales Value (2021-2032) & (US$ Million) Figure 4. Global Over-The-Counter (OTC) Pet Medication Sales (2021-2032) & (Kg) Figure 5. Global Over-The-Counter (OTC) Pet Medication Sales Average Price (US$/g) & (2021-2032) Figure 6. Global Over-The-Counter (OTC) Pet Medication Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Dogs Image Figure 10. Cats Image Figure 11. Others Image Figure 12. Global Over-The-Counter (OTC) Pet Medication Sales Volume by Type (2021 VS 2025 VS 2032) & (Kg) Figure 13. Global Over-The-Counter (OTC) Pet Medication Sales Volume Share 2021 VS 2025 VS 2032 Figure 14. Global Over-The-Counter (OTC) Pet Medication Sales Volume Share by Type (2021-2032) Figure 15. Global Over-The-Counter (OTC) Pet Medication Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global Over-The-Counter (OTC) Pet Medication Sales Value Share 2021 VS 2025 VS 2032 Figure 17. Global Over-The-Counter (OTC) Pet Medication Sales Value Share by Type (2021-2032) Figure 18. Online Sales Image Figure 19. Offline Sales Image Figure 20. Global Over-The-Counter (OTC) Pet Medication Sales Volume by Application (2021 VS 2025 VS 2032) & (Kg) Figure 21. Global Over-The-Counter (OTC) Pet Medication Sales Volume Share 2021 VS 2025 VS 2032 Figure 22. Global Over-The-Counter (OTC) Pet Medication Sales Volume Share by Application (2021-2032) Figure 23. Global Over-The-Counter (OTC) Pet Medication Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 24. Global Over-The-Counter (OTC) Pet Medication Sales Value Share 2021 VS 2025 VS 2032 Figure 25. Global Over-The-Counter (OTC) Pet Medication Sales Value Share by Application (2021-2032) Figure 26. Global Over-The-Counter (OTC) Pet Medication Sales by Region: 2021 VS 2025 VS 2032 (Kg) Figure 27. Global Over-The-Counter (OTC) Pet Medication Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 28. Global Over-The-Counter (OTC) Pet Medication Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 29. Global Over-The-Counter (OTC) Pet Medication Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 30. North America Over-The-Counter (OTC) Pet Medication Sales Value (2021-2032) & (US$ Million) Figure 31. North America Over-The-Counter (OTC) Pet Medication Sales Value Share by Country (%), 2025 VS 2032 Figure 32. Europe Over-The-Counter (OTC) Pet Medication Sales Value (2021-2032) & (US$ Million) Figure 33. Europe Over-The-Counter (OTC) Pet Medication Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Asia-Pacific Over-The-Counter (OTC) Pet Medication Sales Value (2021-2032) & (US$ Million) Figure 35. Asia-Pacific Over-The-Counter (OTC) Pet Medication Sales Value Share by Country (%), 2025 VS 2032 Figure 36. South America Over-The-Counter (OTC) Pet Medication Sales Value (2021-2032) & (US$ Million) Figure 37. South America Over-The-Counter (OTC) Pet Medication Sales Value Share by Country (%), 2025 VS 2032 Figure 38. Middle East & Africa Over-The-Counter (OTC) Pet Medication Sales Value (2021-2032) & (US$ Million) Figure 39. Middle East & Africa Over-The-Counter (OTC) Pet Medication Sales Value Share by Country (%), 2025 VS 2032 Figure 40. USA Over-The-Counter (OTC) Pet Medication Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. USA Over-The-Counter (OTC) Pet Medication Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. USA Over-The-Counter (OTC) Pet Medication Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. Canada Over-The-Counter (OTC) Pet Medication Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. Canada Over-The-Counter (OTC) Pet Medication Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. Canada Over-The-Counter (OTC) Pet Medication Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. Mexico Over-The-Counter (OTC) Pet Medication Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. Mexico Over-The-Counter (OTC) Pet Medication Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. Mexico Over-The-Counter (OTC) Pet Medication Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Germany Over-The-Counter (OTC) Pet Medication Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Germany Over-The-Counter (OTC) Pet Medication Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Germany Over-The-Counter (OTC) Pet Medication Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. France Over-The-Counter (OTC) Pet Medication Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. France Over-The-Counter (OTC) Pet Medication Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. France Over-The-Counter (OTC) Pet Medication Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. U.K. Over-The-Counter (OTC) Pet Medication Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. U.K. Over-The-Counter (OTC) Pet Medication Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. U.K. Over-The-Counter (OTC) Pet Medication Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Italy Over-The-Counter (OTC) Pet Medication Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Italy Over-The-Counter (OTC) Pet Medication Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Italy Over-The-Counter (OTC) Pet Medication Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Spain Over-The-Counter (OTC) Pet Medication Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Spain Over-The-Counter (OTC) Pet Medication Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Spain Over-The-Counter (OTC) Pet Medication Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Russia Over-The-Counter (OTC) Pet Medication Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Russia Over-The-Counter (OTC) Pet Medication Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Russia Over-The-Counter (OTC) Pet Medication Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Netherlands Over-The-Counter (OTC) Pet Medication Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Netherlands Over-The-Counter (OTC) Pet Medication Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Netherlands Over-The-Counter (OTC) Pet Medication Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Nordic Countries Over-The-Counter (OTC) Pet Medication Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Nordic Countries Over-The-Counter (OTC) Pet Medication Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Nordic Countries Over-The-Counter (OTC) Pet Medication Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. China Over-The-Counter (OTC) Pet Medication Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. China Over-The-Counter (OTC) Pet Medication Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. China Over-The-Counter (OTC) Pet Medication Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Japan Over-The-Counter (OTC) Pet Medication Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Japan Over-The-Counter (OTC) Pet Medication Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Japan Over-The-Counter (OTC) Pet Medication Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. South Korea Over-The-Counter (OTC) Pet Medication Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. South Korea Over-The-Counter (OTC) Pet Medication Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. South Korea Over-The-Counter (OTC) Pet Medication Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. India Over-The-Counter (OTC) Pet Medication Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. India Over-The-Counter (OTC) Pet Medication Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. India Over-The-Counter (OTC) Pet Medication Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Australia Over-The-Counter (OTC) Pet Medication Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Australia Over-The-Counter (OTC) Pet Medication Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Australia Over-The-Counter (OTC) Pet Medication Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Southeast Asia Over-The-Counter (OTC) Pet Medication Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Southeast Asia Over-The-Counter (OTC) Pet Medication Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Southeast Asia Over-The-Counter (OTC) Pet Medication Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Brazil Over-The-Counter (OTC) Pet Medication Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Brazil Over-The-Counter (OTC) Pet Medication Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Brazil Over-The-Counter (OTC) Pet Medication Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Argentina Over-The-Counter (OTC) Pet Medication Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Argentina Over-The-Counter (OTC) Pet Medication Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Argentina Over-The-Counter (OTC) Pet Medication Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Chile Over-The-Counter (OTC) Pet Medication Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Chile Over-The-Counter (OTC) Pet Medication Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Chile Over-The-Counter (OTC) Pet Medication Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Colombia Over-The-Counter (OTC) Pet Medication Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Colombia Over-The-Counter (OTC) Pet Medication Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Colombia Over-The-Counter (OTC) Pet Medication Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Peru Over-The-Counter (OTC) Pet Medication Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Peru Over-The-Counter (OTC) Pet Medication Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Peru Over-The-Counter (OTC) Pet Medication Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Saudi Arabia Over-The-Counter (OTC) Pet Medication Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Saudi Arabia Over-The-Counter (OTC) Pet Medication Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Saudi Arabia Over-The-Counter (OTC) Pet Medication Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Israel Over-The-Counter (OTC) Pet Medication Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Israel Arabia Over-The-Counter (OTC) Pet Medication Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Israel Arabia Over-The-Counter (OTC) Pet Medication Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. UAE Over-The-Counter (OTC) Pet Medication Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. UAE Over-The-Counter (OTC) Pet Medication Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. UAE Over-The-Counter (OTC) Pet Medication Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Turkey Over-The-Counter (OTC) Pet Medication Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. Turkey Over-The-Counter (OTC) Pet Medication Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. Turkey Over-The-Counter (OTC) Pet Medication Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Iran Over-The-Counter (OTC) Pet Medication Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 119. Iran Over-The-Counter (OTC) Pet Medication Sales Value Share by Type, 2025 VS 2032 & (%) Figure 120. Iran Over-The-Counter (OTC) Pet Medication Sales Value Share by Application, 2025 VS 2032 & (%) Figure 121. Egypt Over-The-Counter (OTC) Pet Medication Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 122. Egypt Over-The-Counter (OTC) Pet Medication Sales Value Share by Type, 2025 VS 2032 & (%) Figure 123. Egypt Over-The-Counter (OTC) Pet Medication Sales Value Share by Application, 2025 VS 2032 & (%) Figure 124. Over-The-Counter (OTC) Pet Medication Value Chain Figure 125. Manufacturing Cost Structure Figure 126. Over-The-Counter (OTC) Pet Medication Sales Mode & Process Figure 127. Direct Comparison with Distribution Share Figure 128. Distributors Profiles Figure 129. Years Considered Figure 130. Research Process Figure 131. Key Executives Interviewed

Scope & coverage.

Types
  • Dogs
  • Cats
  • Others
Applications
  • Online Sales
  • Offline Sales
Companies covered
  • Merck Animal Health
  • Elanco
  • Zoetis
  • Virbac
  • Vet's Best
  • Vetoquinol
  • Sentry
  • Purdue Pharma L.P.
  • PetIQ
  • Perrigo
  • Nutramax Laboratories
  • Mobedco-Vet
  • Ceva Santé Animale
  • Boehringer Ingelheim
  • Antelope Pets

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Over-The-Counter (OTC) Pet Medication Sales Value (2021-2032)
  4. 1.2.2 Global Over-The-Counter (OTC) Pet Medication Sales Volume (2021-2032)
  5. 1.2.3 Global Over-The-Counter (OTC) Pet Medication Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Over-The-Counter (OTC) Pet Medication Market Dynamics
  1. 2.1 Over-The-Counter (OTC) Pet Medication Industry Trends
  2. 2.2 Over-The-Counter (OTC) Pet Medication Industry Drivers
  3. 2.3 Over-The-Counter (OTC) Pet Medication Industry Opportunities and Challenges
  4. 2.4 Over-The-Counter (OTC) Pet Medication Industry Restraints
3 Over-The-Counter (OTC) Pet Medication Market by Company
  1. 3.1 Global Over-The-Counter (OTC) Pet Medication Company Revenue Ranking in 2025
  2. 3.2 Global Over-The-Counter (OTC) Pet Medication Revenue by Company (2021-2026)
  3. 3.3 Global Over-The-Counter (OTC) Pet Medication Sales Volume by Company (2021-2026)
  4. 3.4 Global Over-The-Counter (OTC) Pet Medication Average Price by Company (2021-2026)
  5. 3.5 Global Over-The-Counter (OTC) Pet Medication Company Ranking (2024-2026)
  6. 3.6 Global Over-The-Counter (OTC) Pet Medication Company Manufacturing Base and Headquarters
  7. 3.7 Global Over-The-Counter (OTC) Pet Medication Company Product Type and Application
  8. 3.8 Global Over-The-Counter (OTC) Pet Medication Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Over-The-Counter (OTC) Pet Medication Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Over-The-Counter (OTC) Pet Medication Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Over-The-Counter (OTC) Pet Medication Market by Type
  1. 4.1 Over-The-Counter (OTC) Pet Medication Type Introduction
  2. 4.1.1 Dogs
  3. 4.1.2 Cats
  4. 4.1.3 Others
  5. 4.2 Global Over-The-Counter (OTC) Pet Medication Sales Volume by Type
  6. 4.2.1 Global Over-The-Counter (OTC) Pet Medication Sales Volume by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Over-The-Counter (OTC) Pet Medication Sales Volume by Type (2021-2032)
  8. 4.2.3 Global Over-The-Counter (OTC) Pet Medication Sales Volume Share by Type (2021-2032)
  9. 4.3 Global Over-The-Counter (OTC) Pet Medication Sales Value by Type
  10. 4.3.1 Global Over-The-Counter (OTC) Pet Medication Sales Value by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Over-The-Counter (OTC) Pet Medication Sales Value by Type (2021-2032)
  12. 4.3.3 Global Over-The-Counter (OTC) Pet Medication Sales Value Share by Type (2021-2032)
5 Over-The-Counter (OTC) Pet Medication Market by Application
  1. 5.1 Over-The-Counter (OTC) Pet Medication Application Introduction
  2. 5.1.1 Online Sales
  3. 5.1.2 Offline Sales
  4. 5.2 Global Over-The-Counter (OTC) Pet Medication Sales Volume by Application
  5. 5.2.1 Global Over-The-Counter (OTC) Pet Medication Sales Volume by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Over-The-Counter (OTC) Pet Medication Sales Volume by Application (2021-2032)
  7. 5.2.3 Global Over-The-Counter (OTC) Pet Medication Sales Volume Share by Application (2021-2032)
  8. 5.3 Global Over-The-Counter (OTC) Pet Medication Sales Value by Application
  9. 5.3.1 Global Over-The-Counter (OTC) Pet Medication Sales Value by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Over-The-Counter (OTC) Pet Medication Sales Value by Application (2021-2032)
  11. 5.3.3 Global Over-The-Counter (OTC) Pet Medication Sales Value Share by Application (2021-2032)
6 Over-The-Counter (OTC) Pet Medication Regional Sales and Value Analysis
  1. 6.1 Global Over-The-Counter (OTC) Pet Medication Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Over-The-Counter (OTC) Pet Medication Sales by Region (2021-2032)
  3. 6.2.1 Global Over-The-Counter (OTC) Pet Medication Sales by Region: 2021-2026
  4. 6.2.2 Global Over-The-Counter (OTC) Pet Medication Sales by Region (2027-2032)
  5. 6.3 Global Over-The-Counter (OTC) Pet Medication Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Over-The-Counter (OTC) Pet Medication Sales Value by Region (2021-2032)
  7. 6.4.1 Global Over-The-Counter (OTC) Pet Medication Sales Value by Region: 2021-2026
  8. 6.4.2 Global Over-The-Counter (OTC) Pet Medication Sales Value by Region (2027-2032)
  9. 6.5 Global Over-The-Counter (OTC) Pet Medication Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Over-The-Counter (OTC) Pet Medication Sales Value (2021-2032)
  12. 6.6.2 North America Over-The-Counter (OTC) Pet Medication Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Over-The-Counter (OTC) Pet Medication Sales Value (2021-2032)
  15. 6.7.2 Europe Over-The-Counter (OTC) Pet Medication Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Over-The-Counter (OTC) Pet Medication Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Over-The-Counter (OTC) Pet Medication Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Over-The-Counter (OTC) Pet Medication Sales Value (2021-2032)
  21. 6.9.2 South America Over-The-Counter (OTC) Pet Medication Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Over-The-Counter (OTC) Pet Medication Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Over-The-Counter (OTC) Pet Medication Sales Value Share by Country, 2025 VS 2032
7 Over-The-Counter (OTC) Pet Medication Country-level Sales and Value Analysis
  1. 7.1 Global Over-The-Counter (OTC) Pet Medication Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Over-The-Counter (OTC) Pet Medication Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Over-The-Counter (OTC) Pet Medication Sales by Country (2021-2032)
  4. 7.3.1 Global Over-The-Counter (OTC) Pet Medication Sales by Country (2021-2026)
  5. 7.3.2 Global Over-The-Counter (OTC) Pet Medication Sales by Country (2027-2032)
  6. 7.4 Global Over-The-Counter (OTC) Pet Medication Sales Value by Country (2021-2032)
  7. 7.4.1 Global Over-The-Counter (OTC) Pet Medication Sales Value by Country (2021-2026)
  8. 7.4.2 Global Over-The-Counter (OTC) Pet Medication Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Over-The-Counter (OTC) Pet Medication Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Over-The-Counter (OTC) Pet Medication Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Over-The-Counter (OTC) Pet Medication Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Over-The-Counter (OTC) Pet Medication Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Over-The-Counter (OTC) Pet Medication Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Over-The-Counter (OTC) Pet Medication Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Over-The-Counter (OTC) Pet Medication Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Over-The-Counter (OTC) Pet Medication Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Over-The-Counter (OTC) Pet Medication Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Over-The-Counter (OTC) Pet Medication Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Over-The-Counter (OTC) Pet Medication Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Over-The-Counter (OTC) Pet Medication Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Over-The-Counter (OTC) Pet Medication Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Over-The-Counter (OTC) Pet Medication Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Over-The-Counter (OTC) Pet Medication Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Over-The-Counter (OTC) Pet Medication Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Over-The-Counter (OTC) Pet Medication Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Over-The-Counter (OTC) Pet Medication Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Over-The-Counter (OTC) Pet Medication Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Over-The-Counter (OTC) Pet Medication Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Over-The-Counter (OTC) Pet Medication Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Over-The-Counter (OTC) Pet Medication Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Over-The-Counter (OTC) Pet Medication Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Over-The-Counter (OTC) Pet Medication Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Over-The-Counter (OTC) Pet Medication Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Over-The-Counter (OTC) Pet Medication Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Over-The-Counter (OTC) Pet Medication Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Over-The-Counter (OTC) Pet Medication Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Over-The-Counter (OTC) Pet Medication Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Over-The-Counter (OTC) Pet Medication Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Over-The-Counter (OTC) Pet Medication Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Over-The-Counter (OTC) Pet Medication Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Over-The-Counter (OTC) Pet Medication Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Over-The-Counter (OTC) Pet Medication Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Over-The-Counter (OTC) Pet Medication Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Over-The-Counter (OTC) Pet Medication Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Over-The-Counter (OTC) Pet Medication Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Over-The-Counter (OTC) Pet Medication Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Over-The-Counter (OTC) Pet Medication Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Over-The-Counter (OTC) Pet Medication Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Over-The-Counter (OTC) Pet Medication Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Over-The-Counter (OTC) Pet Medication Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Over-The-Counter (OTC) Pet Medication Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Over-The-Counter (OTC) Pet Medication Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Over-The-Counter (OTC) Pet Medication Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Over-The-Counter (OTC) Pet Medication Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Over-The-Counter (OTC) Pet Medication Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Over-The-Counter (OTC) Pet Medication Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Over-The-Counter (OTC) Pet Medication Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Over-The-Counter (OTC) Pet Medication Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Over-The-Counter (OTC) Pet Medication Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Over-The-Counter (OTC) Pet Medication Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Over-The-Counter (OTC) Pet Medication Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Over-The-Counter (OTC) Pet Medication Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Over-The-Counter (OTC) Pet Medication Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Over-The-Counter (OTC) Pet Medication Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Over-The-Counter (OTC) Pet Medication Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Over-The-Counter (OTC) Pet Medication Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Over-The-Counter (OTC) Pet Medication Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Over-The-Counter (OTC) Pet Medication Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Over-The-Counter (OTC) Pet Medication Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Over-The-Counter (OTC) Pet Medication Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Over-The-Counter (OTC) Pet Medication Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Over-The-Counter (OTC) Pet Medication Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Over-The-Counter (OTC) Pet Medication Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Over-The-Counter (OTC) Pet Medication Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Over-The-Counter (OTC) Pet Medication Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Over-The-Counter (OTC) Pet Medication Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Over-The-Counter (OTC) Pet Medication Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Over-The-Counter (OTC) Pet Medication Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Over-The-Counter (OTC) Pet Medication Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Over-The-Counter (OTC) Pet Medication Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Over-The-Counter (OTC) Pet Medication Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Over-The-Counter (OTC) Pet Medication Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Over-The-Counter (OTC) Pet Medication Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Over-The-Counter (OTC) Pet Medication Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Over-The-Counter (OTC) Pet Medication Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Over-The-Counter (OTC) Pet Medication Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Over-The-Counter (OTC) Pet Medication Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Over-The-Counter (OTC) Pet Medication Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Over-The-Counter (OTC) Pet Medication Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Over-The-Counter (OTC) Pet Medication Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Over-The-Counter (OTC) Pet Medication Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Over-The-Counter (OTC) Pet Medication Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Merck Animal Health
  2. 8.1.1 Merck Animal Health Company Information
  3. 8.1.2 Merck Animal Health Business Overview
  4. 8.1.3 Merck Animal Health Over-The-Counter (OTC) Pet Medication Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Merck Animal Health Over-The-Counter (OTC) Pet Medication Product Portfolio
  6. 8.1.5 Merck Animal Health Recent Developments
  7. 8.2 Elanco
  8. 8.2.1 Elanco Company Information
  9. 8.2.2 Elanco Business Overview
  10. 8.2.3 Elanco Over-The-Counter (OTC) Pet Medication Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Elanco Over-The-Counter (OTC) Pet Medication Product Portfolio
  12. 8.2.5 Elanco Recent Developments
  13. 8.3 Zoetis
  14. 8.3.1 Zoetis Company Information
  15. 8.3.2 Zoetis Business Overview
  16. 8.3.3 Zoetis Over-The-Counter (OTC) Pet Medication Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Zoetis Over-The-Counter (OTC) Pet Medication Product Portfolio
  18. 8.3.5 Zoetis Recent Developments
  19. 8.4 Virbac
  20. 8.4.1 Virbac Company Information
  21. 8.4.2 Virbac Business Overview
  22. 8.4.3 Virbac Over-The-Counter (OTC) Pet Medication Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Virbac Over-The-Counter (OTC) Pet Medication Product Portfolio
  24. 8.4.5 Virbac Recent Developments
  25. 8.5 Vet's Best
  26. 8.5.1 Vet's Best Company Information
  27. 8.5.2 Vet's Best Business Overview
  28. 8.5.3 Vet's Best Over-The-Counter (OTC) Pet Medication Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Vet's Best Over-The-Counter (OTC) Pet Medication Product Portfolio
  30. 8.5.5 Vet's Best Recent Developments
  31. 8.6 Vetoquinol
  32. 8.6.1 Vetoquinol Company Information
  33. 8.6.2 Vetoquinol Business Overview
  34. 8.6.3 Vetoquinol Over-The-Counter (OTC) Pet Medication Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Vetoquinol Over-The-Counter (OTC) Pet Medication Product Portfolio
  36. 8.6.5 Vetoquinol Recent Developments
  37. 8.7 Sentry
  38. 8.7.1 Sentry Company Information
  39. 8.7.2 Sentry Business Overview
  40. 8.7.3 Sentry Over-The-Counter (OTC) Pet Medication Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Sentry Over-The-Counter (OTC) Pet Medication Product Portfolio
  42. 8.7.5 Sentry Recent Developments
  43. 8.8 Purdue Pharma L.P.
  44. 8.8.1 Purdue Pharma L.P. Company Information
  45. 8.8.2 Purdue Pharma L.P. Business Overview
  46. 8.8.3 Purdue Pharma L.P. Over-The-Counter (OTC) Pet Medication Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Purdue Pharma L.P. Over-The-Counter (OTC) Pet Medication Product Portfolio
  48. 8.8.5 Purdue Pharma L.P. Recent Developments
  49. 8.9 PetIQ
  50. 8.9.1 PetIQ Company Information
  51. 8.9.2 PetIQ Business Overview
  52. 8.9.3 PetIQ Over-The-Counter (OTC) Pet Medication Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 PetIQ Over-The-Counter (OTC) Pet Medication Product Portfolio
  54. 8.9.5 PetIQ Recent Developments
  55. 8.10 Perrigo
  56. 8.10.1 Perrigo Company Information
  57. 8.10.2 Perrigo Business Overview
  58. 8.10.3 Perrigo Over-The-Counter (OTC) Pet Medication Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Perrigo Over-The-Counter (OTC) Pet Medication Product Portfolio
  60. 8.10.5 Perrigo Recent Developments
  61. 8.11 Nutramax Laboratories
  62. 8.11.1 Nutramax Laboratories Company Information
  63. 8.11.2 Nutramax Laboratories Business Overview
  64. 8.11.3 Nutramax Laboratories Over-The-Counter (OTC) Pet Medication Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 Nutramax Laboratories Over-The-Counter (OTC) Pet Medication Product Portfolio
  66. 8.11.5 Nutramax Laboratories Recent Developments
  67. 8.12 Mobedco-Vet
  68. 8.12.1 Mobedco-Vet Company Information
  69. 8.12.2 Mobedco-Vet Business Overview
  70. 8.12.3 Mobedco-Vet Over-The-Counter (OTC) Pet Medication Sales, Value and Gross Margin (2021-2026)
  71. 8.12.4 Mobedco-Vet Over-The-Counter (OTC) Pet Medication Product Portfolio
  72. 8.12.5 Mobedco-Vet Recent Developments
  73. 8.13 Ceva Santé Animale
  74. 8.13.1 Ceva Santé Animale Company Information
  75. 8.13.2 Ceva Santé Animale Business Overview
  76. 8.13.3 Ceva Santé Animale Over-The-Counter (OTC) Pet Medication Sales, Value and Gross Margin (2021-2026)
  77. 8.13.4 Ceva Santé Animale Over-The-Counter (OTC) Pet Medication Product Portfolio
  78. 8.13.5 Ceva Santé Animale Recent Developments
  79. 8.14 Boehringer Ingelheim
  80. 8.14.1 Boehringer Ingelheim Company Information
  81. 8.14.2 Boehringer Ingelheim Business Overview
  82. 8.14.3 Boehringer Ingelheim Over-The-Counter (OTC) Pet Medication Sales, Value and Gross Margin (2021-2026)
  83. 8.14.4 Boehringer Ingelheim Over-The-Counter (OTC) Pet Medication Product Portfolio
  84. 8.14.5 Boehringer Ingelheim Recent Developments
  85. 8.15 Antelope Pets
  86. 8.15.1 Antelope Pets Company Information
  87. 8.15.2 Antelope Pets Business Overview
  88. 8.15.3 Antelope Pets Over-The-Counter (OTC) Pet Medication Sales, Value and Gross Margin (2021-2026)
  89. 8.15.4 Antelope Pets Over-The-Counter (OTC) Pet Medication Product Portfolio
  90. 8.15.5 Antelope Pets Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Over-The-Counter (OTC) Pet Medication Value Chain Analysis
  2. 9.1.1 Over-The-Counter (OTC) Pet Medication Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Over-The-Counter (OTC) Pet Medication Sales Mode & Process
  6. 9.2 Over-The-Counter (OTC) Pet Medication Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Over-The-Counter (OTC) Pet Medication Distributors
  9. 9.2.3 Over-The-Counter (OTC) Pet Medication Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst